annual total liabilities:
$4.17B+$122.37M(+3.02%)Summary
- As of today (May 29, 2025), ALNY annual total liabilities is $4.17 billion, with the most recent change of +$122.37 million (+3.02%) on December 31, 2024.
- During the last 3 years, ALNY annual total liabilities has risen by +$1.12 billion (+36.59%).
- ALNY annual total liabilities is now at all-time high.
Performance
ALNY Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$4.10B-$74.52M(-1.79%)Summary
- As of today (May 29, 2025), ALNY quarterly total liabilities is $4.10 billion, with the most recent change of -$74.52 million (-1.79%) on March 31, 2025.
- Over the past year, ALNY quarterly total liabilities has increased by +$54.72 million (+1.35%).
- ALNY quarterly total liabilities is now -1.79% below its all-time high of $4.17 billion, reached on December 31, 2024.
Performance
ALNY quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ALNY Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.0% | +1.4% |
| 3 y3 years | +36.6% | +35.1% |
| 5 y5 years | +336.3% | +340.7% |
ALNY Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +36.6% | -1.8% | +35.1% |
| 5 y | 5-year | at high | +336.3% | -1.8% | +340.7% |
| alltime | all time | at high | >+9999.0% | -1.8% | >+9999.0% |
ALNY Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $4.10B(-1.8%) |
| Dec 2024 | $4.17B(+3.0%) | $4.17B(+0.0%) |
| Sep 2024 | - | $4.17B(+4.0%) |
| Jun 2024 | - | $4.01B(-0.8%) |
| Mar 2024 | - | $4.04B(-0.2%) |
| Dec 2023 | $4.05B(+9.3%) | $4.05B(+1.1%) |
| Sep 2023 | - | $4.00B(+5.1%) |
| Jun 2023 | - | $3.81B(+4.4%) |
| Mar 2023 | - | $3.65B(-1.4%) |
| Dec 2022 | $3.70B(+21.3%) | $3.70B(+2.8%) |
| Sep 2022 | - | $3.60B(+14.2%) |
| Jun 2022 | - | $3.15B(+4.0%) |
| Mar 2022 | - | $3.03B(-0.7%) |
| Dec 2021 | $3.06B(+27.8%) | $3.06B(+12.5%) |
| Sep 2021 | - | $2.72B(+2.3%) |
| Jun 2021 | - | $2.66B(+14.0%) |
| Mar 2021 | - | $2.33B(-2.6%) |
| Dec 2020 | $2.39B(+150.0%) | $2.39B(+14.3%) |
| Sep 2020 | - | $2.09B(+6.0%) |
| Jun 2020 | - | $1.97B(+112.4%) |
| Mar 2020 | - | $929.89M(-2.8%) |
| Dec 2019 | $956.44M(+250.6%) | $956.44M(+2.3%) |
| Sep 2019 | - | $934.53M(-2.6%) |
| Jun 2019 | - | $959.22M(+105.4%) |
| Mar 2019 | - | $467.01M(+71.2%) |
| Dec 2018 | $272.84M(+19.5%) | $272.84M(+38.1%) |
| Sep 2018 | - | $197.53M(+17.2%) |
| Jun 2018 | - | $168.59M(+0.2%) |
| Mar 2018 | - | $168.33M(-26.3%) |
| Dec 2017 | $228.30M(-33.4%) | $228.30M(-23.8%) |
| Sep 2017 | - | $299.45M(-3.8%) |
| Jun 2017 | - | $311.32M(+2.7%) |
| Mar 2017 | - | $303.02M(-11.5%) |
| Dec 2016 | $342.59M(+181.3%) | $342.59M(+15.0%) |
| Sep 2016 | - | $297.94M(+5.0%) |
| Jun 2016 | - | $283.68M(+121.8%) |
| Mar 2016 | - | $127.90M(+5.0%) |
| Dec 2015 | $121.80M(-15.0%) | $121.80M(+6.3%) |
| Sep 2015 | - | $114.54M(-6.2%) |
| Jun 2015 | - | $122.17M(-7.6%) |
| Mar 2015 | - | $132.28M(-7.7%) |
| Dec 2014 | $143.33M | $143.33M(+75.0%) |
| Sep 2014 | - | $81.88M(-9.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | - | $90.39M(-27.9%) |
| Mar 2014 | - | $125.32M(-16.6%) |
| Dec 2013 | $150.18M(-2.1%) | $150.18M(+0.2%) |
| Sep 2013 | - | $149.92M(-2.9%) |
| Jun 2013 | - | $154.38M(-3.5%) |
| Mar 2013 | - | $160.02M(+4.3%) |
| Dec 2012 | $153.47M(-6.4%) | $153.47M(+5.7%) |
| Sep 2012 | - | $145.19M(+11.5%) |
| Jun 2012 | - | $130.19M(-8.9%) |
| Mar 2012 | - | $142.92M(-12.8%) |
| Dec 2011 | $163.92M(-30.3%) | $163.92M(-10.1%) |
| Sep 2011 | - | $182.35M(-10.7%) |
| Jun 2011 | - | $204.28M(-8.6%) |
| Mar 2011 | - | $223.49M(-4.9%) |
| Dec 2010 | $235.03M(-22.5%) | $235.03M(-6.7%) |
| Sep 2010 | - | $251.96M(-8.3%) |
| Jun 2010 | - | $274.70M(-5.8%) |
| Mar 2010 | - | $291.58M(-3.9%) |
| Dec 2009 | $303.42M(-13.9%) | $303.42M(-3.3%) |
| Sep 2009 | - | $313.65M(-6.1%) |
| Jun 2009 | - | $334.17M(-6.1%) |
| Mar 2009 | - | $355.79M(+0.9%) |
| Dec 2008 | $352.55M(+19.7%) | $352.55M(-6.1%) |
| Sep 2008 | - | $375.62M(-1.4%) |
| Jun 2008 | - | $380.88M(+34.4%) |
| Mar 2008 | - | $283.44M(-3.8%) |
| Dec 2007 | $294.62M(+658.7%) | $294.62M(-5.6%) |
| Sep 2007 | - | $312.16M(+672.9%) |
| Jun 2007 | - | $40.39M(+8.2%) |
| Mar 2007 | - | $37.31M(-3.9%) |
| Dec 2006 | $38.83M(+6.2%) | $38.83M(-2.3%) |
| Sep 2006 | - | $39.75M(+7.3%) |
| Jun 2006 | - | $37.04M(+3.5%) |
| Mar 2006 | - | $35.77M(-2.2%) |
| Dec 2005 | $36.57M(+83.2%) | $36.57M(+81.2%) |
| Sep 2005 | - | $20.18M(-6.0%) |
| Jun 2005 | - | $21.47M(+11.6%) |
| Mar 2005 | - | $19.24M(-3.6%) |
| Dec 2004 | $19.96M(-67.7%) | $19.96M(+13.7%) |
| Sep 2004 | - | $17.56M(-1.3%) |
| Jun 2004 | - | $17.80M(-77.3%) |
| Mar 2004 | - | $78.42M(+26.7%) |
| Dec 2003 | $61.89M(+198.2%) | $61.89M |
| Dec 2002 | $20.76M | - |
FAQ
- What is Alnylam Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals annual total liabilities year-on-year change?
- What is Alnylam Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals quarterly total liabilities year-on-year change?
What is Alnylam Pharmaceuticals annual total liabilities?
The current annual total liabilities of ALNY is $4.17B
What is the all time high annual total liabilities for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high annual total liabilities is $4.17B
What is Alnylam Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, ALNY annual total liabilities has changed by +$122.37M (+3.02%)
What is Alnylam Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of ALNY is $4.10B
What is the all time high quarterly total liabilities for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high quarterly total liabilities is $4.17B
What is Alnylam Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, ALNY quarterly total liabilities has changed by +$54.72M (+1.35%)